Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis - Aiken, J W; Shebuski, R J; Miller, O V; Gorman, R R (J Pharmacol Exp Ther, 1981)